REQUEST A DEMO
Total
USD $0.00
Search more companies

World Medicine Ilac A.S. (Turkiye)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: World Medicine Ilac Sanayi Ve Ticaret Anonim Sirketi Profile Updated: February 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

World Medicine Ilac A.S. is an enterprise in Turkiye, with the main office in Istanbul. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on March 16, 2011. World Medicine Ilac A.S. currently employs 1,700 (2024) people. In its most recent financial highlights, the company reported a net sales revenue increase of 131.1% in 2022. There was a total growth of 91.91% in World Medicine Ilac A.S.’s total assets over the same period. The net profit margin of World Medicine Ilac A.S. increased by 5.13% in 2022.

Headquarters
No:50 15 Temmuz Mahallesi Cami Yolu Caddesi Bagcilar Gunesli
Istanbul; Marmara; Postal Code: 34212

Contact Details: Purchase the World Medicine Ilac A.S. report to view the information.

Website: http://www.worldmedicine.com.tr

Basic Information
Total Employees:
Purchase the World Medicine Ilac A.S. report to view the information.
Outstanding Shares:
Purchase the World Medicine Ilac A.S. report to view the information.
Incorporation Date:
March 16, 2011
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after World Medicine Ilac A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
131.1%
Total operating revenue
131.1%
Operating profit (EBIT)
173.26%
Net Profit (Loss) for the Period
165.17%
Total assets
91.91%
Total equity
115.39%
Operating Profit Margin (ROS)
6.67%
Net Profit Margin
5.13%
Return on Equity (ROE)
7.26%
Debt to Equity Ratio
-6.93%
Quick Ratio
0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?